logo
ResearchBunny Logo
Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients

Medicine and Health

Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients

D. Cantoní, M. Mayora-neto, et al.

In a surprising revelation, researchers, including Diego Cantoní and Martin Mayora-Neto, discovered that antibodies from SARS-CoV-2 infection or vaccination neutralize RaTG13 more efficiently than SARS-CoV-2. Their work suggests that current vaccination strategies could potentially mitigate future RaTG13 spillover, raising important implications for public health.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Related Publications

Explore these studies to deepen your understanding of the subject.

Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
Medicine and Health

Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

A. Gharbaran, C. C. E. Jordans, et al.

Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells
Medicine and Health

Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells

W. Hong, J. Yang, et al.

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
Medicine and Health

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

A. Goubet, A. Dubuisson, et al.

A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug
Medicine and Health

A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug

Q. Liu, Y. Lu, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny